Dirk Bussiere is the Senior Director of the Molecular Pharmacology department at Eli Lilly and Company. Before joining Eli Lilly, Dirk worked at Abbott Laboratories between the protein crystallography, computer-aided drug design, and scientific information, analysis, and management groups. Later he joined Chiron Corporation and built their structural biology and biophysics efforts. Chiron Corporation subsequently was acquired by the Novartis Institutes for BioMedical Research, where he worked for another 14 years.  In 2007, Dirk was named a Novartis Leading Scientist.